DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Nebacumab
Nebacumab
1 Therapeutic Antibodies – from Past to Future Stefan Dubel¨ and Janice M
Phage Display-Based Strategies for Cloning and Optimization of Monoclonal Antibodies Directed Against Human Pathogens
The Two Tontti Tudiul Lui Hi Ha Unit
Medicines Regulations 1984 (SR 1984/143)
WO 2016/176089 Al 3 November 2016 (03.11.2016) P O P C T
Structure, Function, and Therapeutic Use of Igm Antibodies
BMJ Open Is Committed to Open Peer Review. As Part of This Commitment We Make the Peer Review History of Every Article We Publish Publicly Available
(INN) for Biological and Biotechnological Substances
Orphan Drug Dummy File
Designated Indication Cumulative List of All Products That Have Received
1 Supplementary Materials 1 2 Data Sources 3 in Total, 60 Antibodies
INN Working Document 05.179 Update 2011
Stembook 2018.Pdf
(12) Patent Application Publication (10) Pub. No.: US 2016/0184445 A1 Perroth Et Al
International Nonproprietary Names (Inn) for Biological and Biotechnological Substances
(INN) for Biological and Biotechnological Substances
Developments and Challenges for Mab-Based Therapeutics
WO 2017/011544 Al 19 January 2017 (19.01.2017) P O PCT
Top View
(12) United States Patent (10) Patent No.: US 9,446,134 B2 Maggio (45) Date of Patent: *Sep
Orphan Drug Designations and Approvals List As of 12-02-2013 Governs January 1, 2014
Perspectives
Orphan Drug Designation List
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
© Copyright 2018 Dennis Ryan Goulet
ATC-Index Mit DDD-Angaben Für Den Deutschen Arzneimittelmarkt Berlin 2013, 12
Update on Monoclonal Antibody Therapy in the Gram-Negative Sepsis Syndrome
ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
Copyrighted Material
Fig. 2 O W O 2012/149282 A2 1Inn Iiiiiii 1Mil I Mil Il I 1Ill I Mil I Il I I Mill Mi I I
LIST of ORPHAN PRODUCTS DESIGNATIONS and APPROVALS Throughdecember 31,1999 NAME SPONSOR &
Engineered Fc Regions for Site-Specific Conjugation
Guidelines for ATC Classification and DDD Assignment 2021
Guidelines for ATC Classification and DDD Assignment 2011
(12) Patent Application Publication (10) Pub. No.: US 2015/0293.086 A1 MESSMER Et Al
WO 2012/109624 A2 16 August 2012 (16.08.2012) P O P C T
Orphan Drug Designations and Approvals List As of 12‐01‐2014
(INN) for Biological and Biotechnological Substances
[Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
Concept ID Name Class 1319998 Acebutolol Adrenergics 1154343
WO 2013/120629 Al 22 August 2013 (22.08.2013) P O P C T
Niels Vermeer
Australian Statistics on Medicines 2010
ATC Code Title
Orphan Drug Designations and Approvals List As of 03‐01‐2016 Governs April 1, 2016